176 related articles for article (PubMed ID: 5450347)
1. [Abnormal lipid metabolism and coronary insufficiency].
Murakami M; Sekimoto H; Tanaka I; Seo M; Takegoshi T
Saishin Igaku; 1970 Jan; 25(1):101-9. PubMed ID: 5450347
[No Abstract] [Full Text] [Related]
2. [Therapeutic agents for lipid metabolism disorders--with special reference to arterial diseases].
Murakami M; Sekimoto H; Nagai T; Nakata I; Takekoshi T
Nihon Rinsho; 1970 Mar; 28 Suppl():696-9. PubMed ID: 5430846
[No Abstract] [Full Text] [Related]
3. [The effect of retabolyl on the lipid and protein metabolism of coronary atherosclerosis patients].
Savenkov PM; Segal' RG
Kardiologiia; 1969 Jul; 9(7):95-100. PubMed ID: 5372695
[No Abstract] [Full Text] [Related]
4. [Arteriosclerosis with special reference to anticholesteremic agents].
Murakami M; Sekimoto H; Nakada I; Takegoshi T; Iwaki N
Naika; 1970 Jun; 25(6):1082-6. PubMed ID: 5431239
[No Abstract] [Full Text] [Related]
5. [The action of 1,4-dicaffeylquinic acid on the lipid fractions of the blood in atherosclerosis].
Caruzzo C; Carnaghi R; Enrico-Bena L; De Marco G
Minerva Med; 1969 Nov; 60(91):4514-8. PubMed ID: 5357297
[No Abstract] [Full Text] [Related]
6. [The effect of ethyl-chlorophenoxyisobutyrate on the serum lipids in coronary sclerosis].
Keller L; Rétsági G; Sebestyén M; Diczendy S; Erdélyi G
Z Gesamte Inn Med; 1966 Mar; 21(6):169-72. PubMed ID: 5988081
[No Abstract] [Full Text] [Related]
7. Clofibrate and androsterone effect on serum lipids.
Orgain ES; Bogdonoff MD; Cain C
Arch Intern Med; 1967 Jan; 119(1):80-5. PubMed ID: 6015838
[No Abstract] [Full Text] [Related]
8. New trends in lipid management: eight cases to consider.
Smith DA
Mt Sinai J Med; 2005 Mar; 72(2):90-9. PubMed ID: 15770338
[TBL] [Abstract][Full Text] [Related]
9. [Aspects of the relations between physical exertion and homeostasis of lipid metabolism in normal conditions andin patients with atherosclerosis].
Orha I; Moga A
Fiziol Norm Patol; 1970; 16(5):417-25. PubMed ID: 5485829
[No Abstract] [Full Text] [Related]
10. [Value of determining serum cholesterol levels in patients with coronary heart disease].
Stalenhoef AF
Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2545-8. PubMed ID: 9555153
[TBL] [Abstract][Full Text] [Related]
11. [Study of hyperlipemia and hyperglycemia induced in pateints with coronary atherosclerosis].
Babei E; Cucu R; Cristea E; Hodan O
Stud Cercet Med Interna; 1972; 13(5):463-72. PubMed ID: 4645063
[No Abstract] [Full Text] [Related]
12. Clinical, biochemical and pathological studies of long term "clofibrate" therapy.
el-Mehairy MM; Attia O; Nabih AE; Nassar I; Ibrahim WN
J Trop Med Hyg; 1970 Jul; 73(7):177-81. PubMed ID: 5470220
[No Abstract] [Full Text] [Related]
13. [Effect of Sadamin on lipid metabolism in patients with obliterative arteriosclerosis of lower limbs].
Kiersnowska B; Bielawiec M; Lukjan H; Grabowski R; Korfel B
Pol Tyg Lek; 1972 Jan; 27(4):133-5. PubMed ID: 5010169
[No Abstract] [Full Text] [Related]
14. [Behavior of certain parameters of lipid metabolism and blood coagulation in dyslipidemic patients fed a low-fat diet].
Martelli A; Favero A; Billi GC; Rimondini R
Acta Gerontol (Milano); 1972; 22(1):19-32. PubMed ID: 5026650
[No Abstract] [Full Text] [Related]
15. [Comparative study of the effect of hippophae and sunflower oil on patients with coronary arteriosclerosis].
Olziĭkhutag A
Kardiologiia; 1969 Apr; 9(4):78-82. PubMed ID: 5803362
[No Abstract] [Full Text] [Related]
16. [Use of atromide-S (chlorfibrate) for the treatment of patients with coronary arteriosclerosis].
Zadionchenko VS; Arshakuni RO; Zharov EI; Martynov AI; Liusov VA; Belousov IuB
Kardiologiia; 1969 Apr; 9(4):73-7. PubMed ID: 5803361
[No Abstract] [Full Text] [Related]
17. [Modification of lipid metabolism by anabolic agents].
Fiegel G; Bargheer R; Kukwa D
Arzneimittelforschung; 1966 Feb; 16(2):202-6. PubMed ID: 6014014
[No Abstract] [Full Text] [Related]
18. Clinical prevention of coronary heart disease through cholesterol-lowering therapy.
Grundy SM
Curr Ther Endocrinol Metab; 1997; 6():520-6. PubMed ID: 9174799
[No Abstract] [Full Text] [Related]
19. [Therapeutic influence on the blood lipids in manifest coronary sclerosis].
Aschenbeck G
Rev Bras Med; 1971 Dec; 28(12):653-8. PubMed ID: 4259647
[No Abstract] [Full Text] [Related]
20. [Clinical experimental lipid metabolism studies with essential phospholipids taking into account the arteriosclerosis problem].
Hammerl H; Pichler O; Studlar M
Wien Med Wochenschr; 1966 Apr; 116(16):348-52. PubMed ID: 5985190
[No Abstract] [Full Text] [Related]
[Next] [New Search]
